SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Kymera Therapeutics Presents KT-621 Clinical Data for Atopic Dermatitis

Valid market news retained in the public archive without immediate LiveCast distribution.

KYMR

Related stories